2015

Brazzelli M, Campbell M, Gordon A, Blackwood B, Fraser C, Cruickshank M et al.  Sedation in intensive care. Technology Assessment Report submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2015.

Cruickshank, M, Henderson, L, MacLennan, G, Fraser, C, Campbell, M, Blackwood, B, Gordon, A,Brazzelli, M. Alpha2-agonists for sedation of mechanically-ventilated adults in intensive care units: a systematic review. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2015

Cummins E, Scott N, Cruickshank M, Fraser C, Ormerod A, Brazzelli M.  Secukinumab for treating moderate to severe plaque psoriasis. Evidence Review Group report in support of the NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2015.

Glazener, C, Breeman, S, Elders, A, Hemming, C, Cooper, K, Freeman, RF, Smith, A, Hagen, S, Montgomery, I, Kilonzo, M, Boyers, D, Maclennan, G, McDonald, A, McPherson, G,Norrie , J. Clinical and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study: results from the PROSPECT Study Final grant report submitted to the NIHR HTA programme. University of Aberdeen: Health Services Research Unit; 2015

Independent Review Group on Transvaginal Mesh Implants [Glazener, C]. The Scottish Independent Review of the Use, Safety and Efficacy of Transvaginal Mesh Implants in the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in Women. Interim Report. Edinburgh: The Scottish Government; 2015

Robertson C, Lam T, Fielding S, Cummins E, Fraser C, Scotland G et al.  Enzalutamide for treating metastatic hormone-relapsed prostate cancer not previously treated with chemotherapy. Evidence Review Group report in support of the NICE STA Programme.  University of Aberdeen
Health Services Research Unit: 2015.

Scotland, G, Javanbakht, M, Scott, N, Cruickshank, M, Sharma, P, Fraser, C, Simpson, W,Brazzelli, M. Ezetimibe for treating primary (heterozygous-familial and non-familial) hypercholesterolaemia. . Evidence Review Group report in support of the NICE STA Programme. University pf Aberdeen: Health Services Research Unit; 2015

Scotland, G, Neilson, A, Javanbakht, M, Fielding, S, Cruickshank, M, Sharma, P, Fraser, C, Simpson, W,Brazzelli, M. Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Evidence Review Group report in support of the NICE STA Programme. University of Aberdeen: Health Services Research Unit; 2015

Sharma P, Boyers D, Scott N, Hernandez R, Fraser C, Cruickshank M et al.  The clinical and cost-effectiveness of open mesh repairs in adults presenting with a clinically diagnosed unilateral, primary inguinal hernia who are operated in an elective setting: systematic review and economic evaluation. Technology Assessment Report submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2015.